Advances in molecular biology now make it possible to detect diseases sooner, allowing physicians to advise patients on optimal therapies. “Global Molecular Diagnostics Market: Opportunities & Future Forecast” reports that based on its exceptional ability to accurately detect the primary cause of disease, molecular diagnostics has emerged as the fastest growing segment of the in vitro diagnostics (IVD) industry.
Advances in molecular biology now make it possible to detect diseases sooner, allowing physicians to advise patients on optimal therapies. The Diagnostics and Personalized Medicine panel explores the changing world of diagnostics, bringing together executives, experienced venture capitalists, and a physician.
On 11/19/09, the Company announced positive results in a pilot clinical study which included Prelude skin preparation and the placement of 10 Symphony tCGM biosensors on subjects with Type 1 or Type 2 Diabetes.
The 160,000 square-foot facility could bring at least 300 jobs to Georgia.
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker […]
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker […]
Hundreds of companies such as Bain Capital Ventures, Becton Dickinson, Covidien, DePuy Mitek Worldwide, Kimberly-Clark, Medtronic, Novartis BioVenture Fund, Quaker BioVentures, Siemens Venture Capital, Stryker […]
Copyright © 2024 | WordPress Theme by MH Themes